CASY vs UTHR Comparison

Founded in 1968, Casey's General Stores has become the third-largest convenience store retailer in the United States, operating nearly 3,000 locations across 19 states, primarily in the Midwest. In fiscal 2026, the company generated $17.6 billion in revenue from fuel (60% of sales), grocery and general merchandise (26%), prepared food and dispensed beverages (10%), and areas like wholesale fuel distribution (4%). Casey's footprint skews rural, with over 70% of stores in areas with fewer than 20,000 residents.

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.